Category Generic Drugs

Sanofi-Aventis warns on 2010 earns

Jul28

PARIS Sanofi-Aventis SA warned Thursday that its core earnings may fall up to 4 percent this year as a result of the U.S. Food and Drug Administration’s approval of a generic version of its Lovenox, an injected drug for preventing life-threatening blood clots.In a statement, the Paris-based drug maker says its so-called business net [...]

EPS growth in Q2 2010

Jul28

PARIS, July 29 /PRNewswire-FirstCall/

WORLDWIDE HEALTHCARE TRUST PLC

Jul28

Finsbury Worldwide Pharmaceutical Trust PLC Annual Financial Report for the year ended 31 March 2010 A copy of the Company’s Annual Financial Report can be found on the Company’s [...]

Senate panel bans payments to delay generics

Jul28

WASHINGTON In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market.The Senate Appropriations Committee approved the measure, which was inserted into a spending bill that funds the Federal Trade Commission’s budget.The measure would ban [...]

Research from University of the Basque Country has provided new information about pharmacoepidemiology and drug safety

Jul27

A new study, ‘Biosimilars: pharmacovigilance and risk management,’ is now available. "Biosimilars cannot be authorized based on the same requirements that apply to generic medicines. Despite the fact that the biosimilar and reference drug can show similar efficacy, the biosimilar may exhibit different safety profile in terms of nature, seriousness or incidence of adverse reactions," [...]

Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis

Jul27

HORSHAM, Pa., July 28 /PRNewswire/ Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to placebo. Furthermore, the [...]

Judge upholds patent invalidation of Lilly drug

Jul27

INDIANAPOLIS Eli Lilly and Co. said Wednesday the U.S. Court of Appeals for the Federal Circuit upheld a lower court’s ruling that a patent on Lilly’s blockbuster cancer drug Gemzar is invalid.The appeals court upheld a a ruling by the U.S. District Court for the Eastern District of Michigan that specifically said Gemzar’s method-of-use [...]

FTC Testimony: Stopping ‘Pay-for-Delay’ Drug Settlement Agreements is a Top Competition Priority

Jul26

WASHINGTON, July 27 The Federal Trade Commission issued the following news release:In testimony today before the U.S. House of Representatives Committee on the Judiciary, Subcommittee on Courts and Competition Policy, the Federal Trade Commission details its work to promote competition and benefit consumers. According to the FTC testimony delivered by FTC Chairman Jon Leibowitz, [...]

Teva Reports Strong Second Quarter 2010 Results Driven by Growth in All Businesses

Jul26

European Sales Grew 10% in Local Currencies JERUSALEM(BUSINESS WIRE) Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported results for the quarter ended June 30, 2010. [...]

Teva says to close Ratiopharm buyout earlier than expected

Jul26

Israel-based drug maker Teva (TLV:TEVA) expects to complete the acquisition of German generic drugs producer Ratiopharm earlier than expected, Reuters said Tuesday citing Teva’s president and CEO Shlomo Yanai.The takeover will probably close in the current quarter, the top manager said.The owners of Ratiopharm agreed to sell the company to Teva for over EUR3.5bn (USD4.6bn) [...]

Your Ad Here